Holocene Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$83.5M Sell
708,889
-252,151
-26% -$35.2M 0.2% 128
2025
Q4
$157M Sell
961,040
-416,064
-30% -$65.2M 0.33% 82
2025
Q3
$184M Buy
1,377,104
+440,290
+47% +$53.5M 0.42% 55
2025
Q2
$117M Sell
936,814
-23,168
-2% -$2.95M 0.28% 95
2025
Q1
$122M Buy
959,982
+648,878
+209% +$99.9M 0.36% 82
2024
Q4
$44.8M Buy
+311,104
New +$44.6M 0.14% 172
2024
Q2
Sell
-342,388
Closed -$63M 827
2024
Q1
$63M Buy
342,388
+37,474
+12% +$7.14M 0.23% 137
2023
Q4
$54.8M Buy
+304,914
New +$47.5M 0.21% 143
2021
Q3
Sell
-256,780
Closed -$51.3M 949
2021
Q2
$51.3M Buy
256,780
+76,048
+42% +$14.8M 0.29% 119
2021
Q1
$35.1M Sell
180,732
-49,745
-22% -$10.2M 0.22% 132
2020
Q4
$44.2M Sell
230,477
-58,362
-20% -$10.6M 0.28% 127
2020
Q3
$42.6M Buy
+288,839
New +$41.3M 0.32% 96
2018
Q2
Sell
-6,547
Closed -$237K 704
2018
Q1
$237K Buy
+6,547
New +$230K 0.01% 477

Other funds holding RGEN

Holocene Advisors's RGEN Position: Q1 2026 in Review

Holocene Advisors reduced its Repligen (RGEN) stake by 26% in Q1 2026, selling an estimated $35.2M and leaving 708,889 shares worth $83.5M. The position accounts for 0.2% of the portfolio, ranked #128.

Holocene Advisors first reported a position in RGEN in Q1 2018 and has held it in 13 quarters since. The position peaked at $184M in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Holocene Advisors held 708,889 shares of Repligen worth $83.5M as of Q1 2026.
  • Holocene Advisors sold 252,151 Repligen shares in Q1 2026, an estimated $35.2M.
  • Repligen made up 0.2% of Holocene Advisors's portfolio in Q1 2026, its #128 holding.
  • Holocene Advisors first reported a position in Repligen in Q1 2018 and has held it in 13 quarters since.
  • Holocene Advisors's Repligen position peaked at $184M in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.